Unsurprisingly, interest in our technology and upcoming products has been extremely high, and we’ve received a wealth of requests globally to both purchase and partner on commercial opportunities as soon as they become available.
The scale of demand indicated by our potential distribution channel partners has led us to upscale our manufacturing strategy so we are pleased to announce that we have agreed to partner with Plexus, who can manufacture worldwide at the scale required to meet our customers’ needs.
This upscaling also requires higher levels of financial capital and so we have appointed Corporate Finance advisors to oversee a further funding round to pre-fund our larger scale manufacturing needs. This process is underway and if you are interested in becoming a founding shareholder in our fast expanding business, please do not hesitate to contact us.
The COVID-19 pandemic has certainly presented us with challenges over the past months. For example, microbiological testing has been slow, since laboratories around the world have been overwhelmed with demand arising from the pandemic.
Nevertheless, we have made very significant progress towards launching Airora devices:
If you have any questions, please drop us a line. We look forward to hearing from you!
The Airora Team
Dr Wyatt blogs on his lifetime's experience of Indoor Air Quality Issues.